E. Schlicker et al., MODULATION OF NEUROTRANSMITTER RELEASE VIA HISTAMINE H-3 HETERORECEPTORS, Fundamental and clinical pharmacology, 8(2), 1994, pp. 128-137
Presynaptic H-3 receptors occur on histaminergic neurones of the CNS (
autoreceptors) and on non-histaminergic neurones of the central and au
tonomic nervous system (heteroreceptors). H-3 heteroreceptors, most pr
obably located on the postganglionic sympathetic nerve fibres innervat
ing the resistance vessels and the heart, have been identified in the
model of the pithed rat. Furthermore, we could show in superfusion exp
eriments that H-3 heteroreceptors also occur on the sympathetic neuron
es supplying the human saphenous vein and the vasculature of the pig r
etina and on the serotoninergic, dopaminergic and noradrenergic neuron
es in the brain of various mammalian species, including man. The effec
ts of three recently described H-3 receptor ligands were studied in su
perfused mouse brain cortex slices. The potency of the novel H-3 recep
tor agonist imetit exceeded that of R-(-)-alpha-methylhistamine (the r
eference H-3 receptor agonist) by one log unit and that of histamine b
y almost two log units. Clobenpropit was shown to be a competitive H-3
receptor antagonist, exhibiting a pA2 as high as 9.6 (exceeding the p
A2 of the reference H-3 receptor antagonist thioperamide by one log un
it). The irreversible antagonism of N-ethoxycarbonyl-2-ethoxy-1,2-dihy
droquinoline (EEDQ) was also studied. Interactions of the H-3 heterore
ceptor with the dopamine autoreceptor in mouse striatal slices and the
alpha2-autoreceptor in mouse brain cortex slices could be demonstrate
d. Activation of alpha2-autoreceptors decreases the H-3 receptor-media
ted effect. Blockade of alpha2-autoreceptors increases the H-3 recepto
r-mediated effect only if the alpha2-autoreceptors are simultaneously
activated by endogenous noradrenaline. The H-3 receptor-mediated inhib
ition of noradrenaline release in mouse brain cortex slices was attenu
ated by the K+ channel blocker tetraethylammonium but this attenuation
was abolished by reduction of the Ca2+ concentration in the medium (t
o compensate for the facilitatory effect of tetraethylammonium on nora
drenaline release). Accordingly, we assume that the H-3 receptors are
not coupled to voltage-sensitive K+ channels. Pertussis toxin and N-et
hylmaleimide attenuated the H-3 receptor-mediated effect in the mouse
brain cortex, suggesting that the H-3 receptors are coupled to a G pro
tein (eg G(i) or G(o)). However, negative coupling to an adenylate cyc
lase does not appear to exist since an H-3 receptor-mediated inhibitio
n of cAMP accumulation was not obtained in mouse brain cortex membrane
s. H-3 receptor ligands are currently undergoing clinical testing and
might become new remedies for the treatment of diseases of the gastroi
ntestinal and bronchial system and the CNS.